Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001493152-26-000967·Dermata Therapeutics, Inc.
Schedule 13D ownership disclosure
DERMATA THERAPEUTICS INC
Common Stock, Par Value $0.0001 Per Share. · CUSIP: 249845504
Event date: 2025-12-23
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- PROEHL GERALD TReported CIK 0001279191
Shares: 694,530.00 · Class: 24.7%
- Proehl Investment Ventures LLCReported CIK 0001877913
Shares: 79,950.00 · Class: 2.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-26-000967
- Form type
- SCHEDULE 13D/A
- Filer
- Dermata Therapeutics, Inc.
- CIK
- CIK 1853816
- Filed
- Jan 08, 2026
- Reporting period
- Dec 23, 2025
- Description
- Schedule 13D beneficial ownership